Orakl Oncology
PrivateLast Round
Seed
Dec 3, 2024
Total Funding Raised
$14.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Orakl Oncology is a biotechnology company that develops an AI-driven platform using patient-derived tumor avatars to accelerate cancer drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orakl Oncology Comparables
Compare Orakl Oncology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TwinEdge Bioscience | 83% | |
| DeepLife | 83% | |
| QuantHealth | 82% | |
Orakl Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2024 | ||||
| Pre Seed | Oct 4, 2023 |
Orakl Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed, Pre Seed |
| Singular | Seed |
| Speedinvest | Seed, Pre Seed |
| HCVC | Seed, Pre Seed |
| Bpifrance | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 3, 2026
Open roles increased to 121, 3.46x headcount.
- Jul 20, 2026
Open roles increased to 116, 3.6x the trailing average.
Orakl Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orakl Oncology's valuation, stock price, and market status.